CASSAVA PHARMA Trademark
Trademark Overview
On Friday, November 1, 2024, a trademark application was filed for CASSAVA PHARMA with the United States Patent and Trademark Office. The USPTO has given the CASSAVA PHARMA trademark a serial number of 98833031. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, November 1, 2024. This trademark is owned by Griffin Gamma LLC. The CASSAVA PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development
General Information
Serial Number | 98833031 |
Word Mark | CASSAVA PHARMA |
Filing Date | Friday, November 1, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Friday, November 1, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 0 - NOT AVAILABLE |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Description of Mark | The mark consists of a shield with a griffin facing left on it's hind legs with the text CASSAVA PHARMA directly to the right and enclosed in a rectangle. |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
NOT AVAILABLE | "PHARMA" |
Goods and Services | Pharmaceutical research and development |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, November 1, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Griffin Gamma LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Fishkill, NY 12524 |
Trademark Events
Event Date | Event Description |
Friday, November 1, 2024 | NEW APPLICATION ENTERED |